Published in Vaccine Weekly, November 4th, 1996
The research was conducted at Kaiser Permanente Pediatric Vaccine Study Center of Northern California, Oakland. In a study published in a recent issue of The Pediatric Infectious Disease Journal, researchers found that the introduction of the HibTITER vaccine for use in infants coincided with the virtual disappearance of invasive Haemophilus influenzae type b (Hib) disease within the Kaiser Permanente system.
The post-approval surveillance study followed more than 60,000...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.